Eisai Inc.
Organisation
Trials
Phase 2Active, not recruiting105 people19 Sept 2024clinicaltrials.gov
CollaboratorPhase 3Active, not recruiting40 people25 Apr 2024clinicaltrials.gov
Phase 1Completed160 people9 Sept 2022clinicaltrials.gov
CollaboratorPhase 2/3Active, not recruiting197 people8 Mar 2022clinicaltrials.gov
Phase 1Completed60 people16 Sept 2021clinicaltrials.gov
CollaboratorPhase 3Terminated863 people2 Jul 2021clinicaltrials.gov
CollaboratorPhase 3Completed201 people20 Jan 2021clinicaltrials.gov
Phase 3Active, not recruiting1,400 people13 Jul 2020clinicaltrials.gov
Phase 1/2Recruiting182 people9 Mar 2020clinicaltrials.gov
Phase 1/2Active, not recruiting301 people5 Jul 2019clinicaltrials.gov
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Phase 3Active, not recruiting1,906 people25 Mar 2019clinicaltrials.gov
CollaboratorPhase 3Completed761 people4 Feb 2019clinicaltrials.gov
Phase 3Completed827 people7 May 2018clinicaltrials.gov
CollaboratorPhase 1Completed11 people27 Oct 2017clinicaltrials.gov
Phase 1/2Completed64 people10 Aug 2017clinicaltrials.gov
Phase 2Completed343 people2 Jun 2017clinicaltrials.gov
Phase 2Completed41 people27 Sept 2016clinicaltrials.gov
Phase 3Active, not recruiting1,069 people23 Jun 2016clinicaltrials.gov
Phase 4Completed302 people21 Jan 2016clinicaltrials.gov
CollaboratorPhase 4Completed40 people21 Dec 2015clinicaltrials.gov